MNCs, Corporates to Enter Pharma Retail (India)
This article was originally published in PharmAsia News
Executive Summary
India's drug retail industry may be moving toward consolidation as large Indian companies as well as global players are looking to it for major opportunities. Today India's drug retail market generates 450 billion rupees per year and is handled by around 550,000 operations. Hong Kong-based Zuellig Pharma and U.S.-based Cardinal Health are rumored to be eyeing opportunities to expand in India. Zuellig Pharma is one of Asia's largest drug logistics providers, and views India as "a major market with vast potential," says Nike Ampton, managing director of Zuellig Pharma India. India's Reliance Anil Dhirubhai Ambani Group is investing 12 billion rupees to build a large drug distribution network in India. Reliance Industries retail arm Reliance Retail in India says it may begin purchasing drugs directly from pharmaceutical manufacturers as a way to comb out spurious products. (Click here for more